Skip to main content
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1976;69(Suppl 1):9–13.

Individual Variability in Response to Haloperidol

Anders O Forsman
PMCID: PMC1863621  PMID: 1019146

Full text

PDF
9

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Forsman A., Mårtensson E., Nyberg G., Ohman R. A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients. Naunyn Schmiedebergs Arch Pharmacol. 1974;286(2):113–124. doi: 10.1007/BF00501606. [DOI] [PubMed] [Google Scholar]
  2. Gibaldi M., Boyes R. N., Feldman S. Influence of first-pass effect on availability of drugs on oral administration. J Pharm Sci. 1971 Sep;60(9):1338–1340. doi: 10.1002/jps.2600600909. [DOI] [PubMed] [Google Scholar]
  3. KUTT H., WOLK M., SCHERMAN R., MCDOWELL F. INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY. Neurology. 1964 Jun;14:542–548. doi: 10.1212/wnl.14.6.542. [DOI] [PubMed] [Google Scholar]
  4. Schou M., Baastrup P. C., Grof P., Weis P., Angst J. Pharmacological and clinical problems of lithium prophylaxis. Br J Psychiatry. 1970 Jun;116(535):615–619. doi: 10.1192/bjp.116.535.615. [DOI] [PubMed] [Google Scholar]
  5. Smith T. W., Butler V. P., Jr, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med. 1969 Nov 27;281(22):1212–1216. doi: 10.1056/NEJM196911272812203. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES